mefloquine has been researched along with Infection, Mycobacterium avium-intracellulare in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aralar, P; Bermudez, LE; Chee, CB; Ellis, WY; Green, CE; Inderlied, CB; Kolonoski, P; Lewin, AH; Parman, T; Petrofsky, M; Young, LS | 1 |
| Bermudez, LE; Inderlied, CB; Kolonoski, P; Petrofsky, M; Wu, M; Young, LS | 1 |
| Bermudez, LE; Kolonoski, P; Petrofsky, M; Reynolds, R; Seitz, LE; Wu, M; Young, LS | 1 |
| Aralar, PA; Bermudez, LE; Inderlied, CB; Kolonoski, P; Wu, M; Young, LS | 1 |
| Bermudez, LE; Young, LS | 1 |
| Binstock, P; Keating, M; Kontoyiannis, DP; Nannini, EC; Samonis, G | 1 |
1 review(s) available for mefloquine and Infection, Mycobacterium avium-intracellulare
| Article | Year |
|---|---|
Perspective on animal models: chronic intracellular infections.
Topics: Animals; Antitubercular Agents; Chronic Disease; Disease Models, Animal; Humans; Mefloquine; Mice; Mice, Inbred C57BL; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Predictive Value of Tests | 2001 |
5 other study(ies) available for mefloquine and Infection, Mycobacterium avium-intracellulare
| Article | Year |
|---|---|
Identification of (+)-erythro-mefloquine as an active enantiomer with greater efficacy than mefloquine against Mycobacterium avium infection in mice.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Female; Humans; Liver; Mefloquine; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Spleen; Stereoisomerism | 2012 |
Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antimalarials; Aza Compounds; Clarithromycin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Mefloquine; Mice; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quinolines | 2003 |
SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Colony Count, Microbial; Drug Interactions; Drug Therapy, Combination; Female; Fluoroquinolones; Liver; Mefloquine; Mice; Mice, Inbred C57BL; Moxifloxacin; Mycobacterium avium-intracellulare Infection; Quinolines; Spleen; Thioacetazone | 2004 |
Mefloquine is active in vitro and in vivo against Mycobacterium avium complex.
Topics: Animals; Antimalarials; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Synergism; Ethambutol; Female; Humans; Macrophages; Mefloquine; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Radiometry; U937 Cells | 1999 |
Successful treatment of refractory disseminated Mycobacterium avium complex infection with the addition of linezolid and mefloquine.
Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Clarithromycin; Drug Therapy, Combination; Ethambutol; Fatal Outcome; Fluoroquinolones; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Linezolid; Male; Mefloquine; Middle Aged; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Oxazolidinones; Quinolines | 2002 |